PAVmed (PAVM) Price & Analysis

Compare

486 Followers

PAVM Stock Chart & Stats

Day’s Range― - ―

52-Week Range$0.55 - $1.90

Previous CloseN/A

Volume127.06K

Average Volume (3M)156.34K

Market Cap

$10.89M

Enterprise Value$6.55B

Total Cash (Recent Filing)$2.70B

Total Debt (Recent Filing)$9.24B

Price to Earnings (P/E)0.9

Beta1.78

Next Earnings

Aug 19, 2025

EPS Estimate

-0.13

Last Dividend Ex-Date

Jan 11, 2024

Dividend YieldN/A

Share Statistics

EPS (TTM)0.34

Shares Outstanding17,294,619

10 Day Avg. Volume293,799

30 Day Avg. Volume156,344

Financial Highlights & Ratios

PEG Ratio<0.01

Price to Book (P/B)0.20

Price to Sales (P/S)0.00

P/FCF Ratio>-0.01

Enterprise Value/Market Cap601.19

Enterprise Value/Revenue314.22

Enterprise Value/Gross Profit-222.13

Enterprise Value/Ebitda-1.21

Forecast

1Y Price Target

$9.17

Price Target Upside1310.77% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering3

PAVmed News

PremiumCompany Announcements

PAVmed’s Earnings Call: Optimism Amid Challenges

7d ago

PAVM

PremiumRatings

PAVmed’s Strategic Advancements and Growth Potential Drive Buy Rating

8d ago

PAVM

PremiumCompany Announcements

Pavmed Inc. Reports Turnaround with Strong Q1 Earnings

8d ago

PAVM

PremiumCompany Announcements

PAVmed Reports Q1 2025 Financial Results and Updates

9d ago

PAVM

PremiumThe Fly

PAVmed files to sell 3.33M shares of common stock for holders

2M ago

PAVM

PremiumCompany Announcements

Pavmed’s Strategic Growth and Financial Challenges

2M ago

PAVM

PremiumRatings

PAVmed’s Strategic Positioning and Growth Potential Justify Buy Rating Despite Revised Revenue Estimates

2M ago

PAVM

PremiumCompany Announcements

PAVmed Reports Strong Q4 Results and Strategic Progress

2M ago

PAVM

See All PAVM News

See All News >

Bulls Say, Bears Say

Bulls Say

CommercializationVeris Health completed a pilot program with a major cancer center and is finalizing a commercial contract, indicating progress in its commercialization efforts.

EarningsLucid Diagnostics reported strong EsoGuard testing results and is expected to receive Medicare coverage, which could drive further growth.

Growth OpportunitiesPAVmed is seeking to diversify its portfolio into the biopharma sector, which is viewed favorably and could enhance growth opportunities.

Bears Say

Development ChallengesPAVmed’s devices still have long development and commercialization challenges ahead, but the ~billion dollars market potential presents high rewards for the risks.

Revenue ProjectionsRevenue estimates for 2025 and 2026 have been lowered due to a slower expected ramp in patients.

Financials

Income Statement >

Options Prices

Detailed Option Prices >

Ownership Overview

5.78%

Insiders

0.92% Mutual Funds

4.38% Other Institutional Investors

94.24% Public Companies and Individual Investors

Detailed Ownership Overview >

PAVM FAQ

What was PAVmed Inc’s price range in the past 12 months?

PAVmed Inc lowest stock price was $0.55 and its highest was $1.90 in the past 12 months.

What is PAVmed Inc’s market cap?

PAVmed Inc’s market cap is $10.89M.

When is PAVmed Inc’s upcoming earnings report date?

PAVmed Inc’s upcoming earnings report date is Aug 19, 2025 which is in 87 days.

How were PAVmed Inc’s earnings last quarter?

PAVmed Inc released its earnings results on May 15, 2025. The company reported $0.34 earnings per share for the quarter, beating the consensus estimate of N/A by $0.34.

Is PAVmed Inc overvalued?

According to Wall Street analysts PAVmed Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does PAVmed Inc pay dividends?

PAVmed Inc pays a Notavailable dividend of $0.551 which represents an annual dividend yield of N/A. See more information on PAVmed Inc dividends here

What is PAVmed Inc’s EPS estimate?

PAVmed Inc’s EPS estimate is -0.13.

How many shares outstanding does PAVmed Inc have?

PAVmed Inc has 17,294,619 shares outstanding.

What happened to PAVmed Inc’s price movement after its last earnings report?

PAVmed Inc reported an EPS of $0.34 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -13.699%.

Which hedge fund is a major shareholder of PAVmed Inc?

Among the largest hedge funds holding PAVmed Inc’s share is Cruiser Capital Advisors, Llc. It holds PAVmed Inc’s shares valued at 0.

Company Description

PAVmed Inc

PAVmed Inc. (PAVM) is a diversified commercial-stage medical technology company operating in the healthcare sector. The company focuses on developing and commercializing innovative medical devices and technologies. PAVmed's core products and services are designed to address unmet clinical needs and improve patient care, including minimally invasive diagnostic tools and therapeutic treatments. The company's portfolio includes products such as EsoCheck, a device for detecting esophageal conditions, and CarpX, a minimally invasive device for treating carpal tunnel syndrome.

PAVM Company Deck

PAVM Earnings Call

Q1 2025

0:00 / 0:00

Earnings Call Sentiment|Positive

The earnings call presented a mix of positive developments, such as a strengthened balance sheet, progress in diagnostic and health platforms, and strategic expansion plans. However, the company still faces challenges, particularly in securing Medicare coverage for Lucid and navigating potential market volatility. Overall, the positives and strategic directions appear to slightly outweigh the uncertainties and dependencies.Read More>

PAVM Stock 12 Month Forecast

Average Price Target

$9.17

▲( 1310.77% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"20":"$20","-1":"-$1","4.25":"$4.25","9.5":"$9.5","14.75":"$14.75"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":19.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$19.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":9.17,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$9.17</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":4,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$4.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[-1,4.25,9.5,14.75,20],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2023","6":"May<br/>2024","9":"Sep<br/>2024","12":"May<br/>2025","25":"May<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.82,2.256923076923077,3.693846153846154,5.130769230769231,6.567692307692308,8.004615384615384,9.441538461538462,10.87846153846154,12.315384615384616,13.752307692307692,15.18923076923077,16.626153846153848,18.063076923076924,{"y":19.5,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.82,1.462307692307692,2.1046153846153843,2.7469230769230766,3.389230769230769,4.031538461538461,4.673846153846154,5.316153846153846,5.958461538461538,6.600769230769231,7.243076923076923,7.8853846153846145,8.527692307692307,{"y":9.17,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.82,1.0646153846153845,1.3092307692307692,1.5538461538461537,1.7984615384615386,2.043076923076923,2.2876923076923075,2.5323076923076924,2.776923076923077,3.0215384615384613,3.266153846153846,3.5107692307692306,3.755384615384615,{"y":4,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":5.87,"date":1682899200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.89,"date":1690848000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.81,"date":1693526400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.28,"date":1698796800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.87,"date":1701388800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.74,"date":1709251200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.31,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.45,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.8,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.91,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.03,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.74,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.82,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >